Literature DB >> 8692865

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

S W Young1, F Qing, A Harriman, J L Sessler, W C Dow, T D Mody, G W Hemmi, Y Hao, R A Miller.   

Abstract

Gadolinium(III) texaphyrin (Gd-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance imaging (MRI). This porphyrin-like complex has a high electron affinity [E1/2 (red.) approximately = -0.08 V versus normal hydrogen electrode] and forms a long-lived pi-radical cation upon exposure to hydrated electrons, reducing ketyl radicals, or superoxide ions. Consistent with these chemical findings, Gd-tex2+ was found to be an efficient radiation sensitizer in studies carried out with HT29 cells in in vitro as well as in in vivo single and multifraction irradiation studies with a murine mammary carcinoma model. Selective localization of Gd-tex2+ in tumors was confirmed by MRI scanning.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692865      PMCID: PMC39073          DOI: 10.1073/pnas.93.13.6610

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix.

Authors:  E R Watson; K E Halnan; S Dische; M I Saunders; I S Cade; J B McEwen; G Wiernik; D J Perrins; I Sutherland
Journal:  Br J Radiol       Date:  1978-11       Impact factor: 3.039

2.  The phenomenon of reoxygenation and its implications for fractionated radiotherapy.

Authors:  R F Kallman
Journal:  Radiology       Date:  1972-10       Impact factor: 11.105

3.  Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

Authors:  S C Rockwell; R F Kallman; L F Fajardo
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Oxygen diffusion and the distribution of cellular radiosensitivity in tumours.

Authors:  I F Tannock
Journal:  Br J Radiol       Date:  1972-07       Impact factor: 3.039

Review 5.  Determinants of radiosensitivity.

Authors:  A Russo; J Mitchell; T Kinsella; G Morstyn; E Glatstein
Journal:  Semin Oncol       Date:  1985-09       Impact factor: 4.929

6.  The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.

Authors:  M I Saunders; P J Anderson; M H Bennett; S Dische; A Minchinton; M R Stratford; M Tothill
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-09       Impact factor: 7.038

7.  A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.

Authors:  T J Kinsella; A Russo; J B Mitchell; J Rowland; J Jenkins; J Schwade; C E Myers; J M Collins; J Speyer; P Kornblith
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-01       Impact factor: 7.038

8.  Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.

Authors:  Z P Pavelic; C W Porter; L M Allen; E Mihich
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

9.  A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.

Authors:  J T Roberts; N M Bleehen; P Workman; M I Walton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-09       Impact factor: 7.038

10.  A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer.

Authors:  T J Kinsella; A Russo; J B Mitchell; J M Collins; J Rowland; D Wright; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-11       Impact factor: 7.038

View more
  33 in total

Review 1.  Radiotherapy for brain tumors.

Authors:  M P Mehta; W A Tomé; G H Olivera
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

2.  Bismuth- and lead-texaphyrin complexes: towards potential α-core emitters for radiotherapy.

Authors:  Christian Preihs; Jonathan F Arambula; Vincent M Lynch; Zahid H Siddik; Jonathan L Sessler
Journal:  Chem Commun (Camb)       Date:  2010-10-04       Impact factor: 6.222

Review 3.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

Review 4.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

Review 5.  Transition-metal complexes of expanded porphyrins.

Authors:  Jonathan L Sessler; Elisa Tomat
Journal:  Acc Chem Res       Date:  2007-03-31       Impact factor: 22.384

6.  Screening of ligands for redox-active europium using magnetic resonance imaging.

Authors:  Brooke A Corbin; Lina A Basal; Susan A White; Yimin Shen; E Mark Haacke; Kenneth W Fishbein; Matthew J Allen
Journal:  Bioorg Med Chem       Date:  2018-04-04       Impact factor: 3.641

7.  Parts per billion detection of uranium with a porphyrinoid-containing nanoparticle and in vivo photoacoustic imaging.

Authors:  I-Ting Ho; Jonathan L Sessler; Sanjiv Sam Gambhir; Jesse V Jokerst
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

8.  Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin) in CD1 mice following intravenous and intraperitoneal injection.

Authors:  G W Boswell; D R Miles; P A Thiemann; M Mesfin
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

Review 9.  Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review.

Authors:  G Brandon Gunn; Karl E Anderson; Abhilasha J Patel; Juan Gallegos; Csilla Kormos Hallberg; Gagan Sood; Sandra S Hatch; Giuseppe Sanguineti
Journal:  Head Neck       Date:  2010-08       Impact factor: 3.147

10.  Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.

Authors:  Natalie M Barkey; Christian Preihs; Heather H Cornnell; Gary Martinez; Adam Carie; Josef Vagner; Liping Xu; Mark C Lloyd; Vincent M Lynch; Victor J Hruby; Jonathan L Sessler; Kevin N Sill; Robert J Gillies; David L Morse
Journal:  J Med Chem       Date:  2013-08-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.